GE HealthCare Technologies Total Liabilities and Share Holders Equity 2020-2024 | GEHC
GE HealthCare Technologies total liabilities and share holders equity from 2020 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- GE HealthCare Technologies total liabilities and share holders equity for the quarter ending September 30, 2024 was $33.855B, a 4.55% increase year-over-year.
- GE HealthCare Technologies total liabilities and share holders equity for 2023 was $32.454B, a 17.85% increase from 2022.
- GE HealthCare Technologies total liabilities and share holders equity for 2022 was $27.539B, a 4.68% increase from 2021.
- GE HealthCare Technologies total liabilities and share holders equity for 2021 was $26.308B, a 8.59% increase from 2020.
| GE HealthCare Technologies Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2023 | $32,454 |
| 2022 | $27,539 |
| 2021 | $26,308 |
| 2020 | $24,228 |
| 2019 | $0 |
| GE HealthCare Technologies Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $33,855 |
| 2024-06-30 | $31,852 |
| 2024-03-31 | $32,210 |
| 2023-12-31 | $32,454 |
| 2023-09-30 | $32,382 |
| 2023-06-30 | $32,311 |
| 2023-03-31 | $32,637 |
| 2022-12-31 | $27,539 |
| 2022-09-30 | $26,067 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | |
| 2021-09-30 | $0 |
| 2020-12-31 | $24,228 |
| 2019-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $39.743B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.059B | 26.03 |
| Stryker (SYK) | United States | $139.868B | 31.52 |
| Boston Scientific (BSX) | United States | $124.863B | 35.90 |
| Medtronic (MDT) | Ireland | $114.537B | 17.04 |
| EssilorLuxottica (ESLOY) | France | $110.799B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.365B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
| ResMed (RMD) | United States | $35.761B | 29.39 |
| Terumo (TRUMY) | Japan | $28.532B | 40.29 |
| Koninklijke Philips (PHG) | Netherlands | $25.454B | 19.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.582B | 13.74 |
| Baxter (BAX) | United States | $18.264B | 12.39 |
| Insulet (PODD) | United States | $16.648B | 70.04 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.052B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.282B | 35.10 |
| BellRing Brands (BRBR) | United States | $8.726B | 36.90 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $8.016B | 19.24 |
| ICU Medical (ICUI) | United States | $4.201B | 40.09 |
| TG Therapeutics (TGTX) | United States | $3.771B | 0.00 |
| Haemonetics (HAE) | United States | $3.763B | 18.61 |
| Envista Holdings (NVST) | United States | $3.662B | 27.28 |
| Prestige Consumer Healthcare (PBH) | United States | $3.657B | 18.22 |
| Perrigo (PRGO) | Ireland | $3.466B | 10.95 |
| Neogen (NEOG) | United States | $3.127B | 36.08 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.988B | 18.00 |
| QuidelOrtho (QDEL) | United States | $2.628B | 16.56 |
| Agios Pharmaceuticals (AGIO) | United States | $2.557B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.260B | 38.14 |
| LeMaitre Vascular (LMAT) | United States | $2.165B | 52.65 |
| Curaleaf Holdings (CURLF) | Canada | $2.023B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.960B | 0.00 |
| Warby Parker (WRBY) | United States | $1.769B | 0.00 |
| AtriCure (ATRC) | United States | $1.641B | 0.00 |
| InMode (INMD) | Israel | $1.460B | 8.78 |
| AdaptHealth (AHCO) | United States | $1.365B | 9.85 |
| Verano Holdings (VRNOF) | United States | $1.231B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.179B | 0.00 |
| Evolus (EOLS) | United States | $1.036B | 0.00 |
| Owens & Minor (OMI) | United States | $0.925B | 7.23 |
| National Vision Holdings (EYE) | United States | $0.915B | 29.08 |
| Phibro Animal Health (PAHC) | United States | $0.906B | 18.80 |
| CeriBell (CBLL) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.844B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.542B | 16.36 |
| Surmodics (SRDX) | United States | $0.536B | 113.85 |
| Quanterix (QTRX) | United States | $0.532B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.515B | 0.00 |
| Valneva SE (VALN) | France | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.398B | 33.56 |
| Viemed Healthcare (VMD) | United States | $0.331B | 35.54 |
| Aurora Cannabis (ACB) | Canada | $0.328B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.315B | 8.12 |
| TerrAscend (TSNDF) | Canada | $0.309B | 0.00 |
| Jin Medical (ZJYL) | China | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Cerus (CERS) | United States | $0.290B | 0.00 |
| Biote (BTMD) | United States | $0.280B | 12.93 |
| Ayr Wellness (AYRWF) | United States | $0.279B | 0.00 |
| Zynex (ZYXI) | United States | $0.255B | 53.33 |
| Omeros (OMER) | United States | $0.246B | 0.00 |
| High Tide (HITI) | Canada | $0.234B | 97.00 |
| MacroGenics (MGNX) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 15.14 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Brainsway (BWAY) | Israel | $0.172B | 206.40 |
| FitLife Brands (FTLF) | United States | $0.145B | 19.54 |
| Rockwell Medical (RMTI) | United States | $0.121B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.117B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 23.90 |
| Fonar (FONR) | United States | $0.092B | 9.51 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.079B | 0.00 |
| InterCure (INCR) | Israel | $0.079B | 0.00 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.064B | 1.63 |
| MariMed (MRMD) | United States | $0.062B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.045B | 0.00 |
| Exagen (XGN) | United States | $0.043B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 17.87 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |